These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9586697)

  • 21. Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations.
    Hatakeyama S; Moriya K; Saijo M; Morisawa Y; Kurane I; Koike K; Kimura S; Morikawa S
    Clin Diagn Lab Immunol; 2005 Apr; 12(4):520-4. PubMed ID: 15817760
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-dependent neutralizing-antibody responses to vaccinia.
    Belshe RB; Newman FK; Frey SE; Couch RB; Treanor JJ; Tacket CO; Yan L
    J Infect Dis; 2004 Feb; 189(3):493-7. PubMed ID: 14745707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8.
    Saito T; Fujii T; Kanatani Y; Saijo M; Morikawa S; Yokote H; Takeuchi T; Kuwabara N
    JAMA; 2009 Mar; 301(10):1025-33. PubMed ID: 19278946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetics of formation of neutralizing antibodies against vaccinia virus following re-vaccination.
    Stienlauf S; Shoresh M; Solomon A; Lublin-Tennenbaum T; Atsmon Y; Meirovich Y; Katz E
    Vaccine; 1999 Jan; 17(3):201-4. PubMed ID: 9987155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical responses to smallpox vaccine in vaccinia-naive and previously vaccinated populations: undiluted and diluted Lancy-Vaxina vaccine in a single-blind, randomized, prospective trial.
    Kim SH; Yeo SG; Jang HC; Park WB; Lee CS; Lee KD; Kim HB; Kim NJ; Kim YT; Jee Y; Cho H; Oh MD; Choe KW
    J Infect Dis; 2005 Sep; 192(6):1066-70. PubMed ID: 16107961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibodies to the A27 protein of vaccinia virus neutralize and protect against infection but represent a minor component of Dryvax vaccine--induced immunity.
    He Y; Manischewitz J; Meseda CA; Merchlinsky M; Vassell RA; Sirota L; Berkower I; Golding H; Weiss CD
    J Infect Dis; 2007 Oct; 196(7):1026-32. PubMed ID: 17763325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH; Yeo SG; Park KH; Bang JW; Kim HB; Kim NJ; Jee Y; Cho H; Oh MD; Choe KW
    Clin Microbiol Infect; 2007 Jan; 13(1):91-3. PubMed ID: 17184294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
    Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
    Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
    Hsieh SM; Chen SY; Sheu GC; Hung MN; Chou WH; Chang SC; Hsu KH
    Vaccine; 2006 Jan; 24(4):510-5. PubMed ID: 16139395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.
    Xiao Y; Aldaz-Carroll L; Ortiz AM; Whitbeck JC; Alexander E; Lou H; Davis HL; Braciale TJ; Eisenberg RJ; Cohen GH; Isaacs SN
    Vaccine; 2007 Jan; 25(7):1214-24. PubMed ID: 17098336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Experiences with improvement of the neutralization reaction with vaccinia virus in chick fibroblast cultures.
    Aksenov OA; Smorodintsev AA
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(4):488-98. PubMed ID: 6006816
    [No Abstract]   [Full Text] [Related]  

  • 32. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions.
    Fogg C; Lustig S; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2004 Oct; 78(19):10230-7. PubMed ID: 15367588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titers.
    Katz JB
    J Biol Stand; 1987 Oct; 15(4):389-92. PubMed ID: 3680308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of immunity to vaccinia virus by using diluted inactivated vaccinia vaccine solution for skin testing.
    Somekh E; Smetana Z; Tanay A; Dalal I; Babai I; Mendelson E
    Vaccine; 2004 Dec; 23(3):321-4. PubMed ID: 15530675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular enveloped vaccinia virus escapes neutralization.
    Ichihashi Y
    Virology; 1996 Mar; 217(2):478-85. PubMed ID: 8610439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid detection of anti-Vaccinia virus neutralizing antibodies.
    Kramski M; Drozd A; Lichtfuss GF; Dabrowski PW; Ellerbrok H
    Virol J; 2011 Mar; 8():139. PubMed ID: 21439060
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.
    Leddy JP; Simons RL; Douglas RG
    J Immunol; 1977 Jan; 118(1):28-34. PubMed ID: 187701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge.
    Lustig S; Fogg C; Whitbeck JC; Eisenberg RJ; Cohen GH; Moss B
    J Virol; 2005 Nov; 79(21):13454-62. PubMed ID: 16227266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cellular toxicity of nanogenomedicine in MCF-7 cell line: MTT assay.
    Ahmadian S; Barar J; Saei AA; Fakhree MA; Omidi Y
    J Vis Exp; 2009 Apr; (26):. PubMed ID: 19352311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of modified vaccinia virus Ankara as an alternative vaccine against smallpox in chronically HIV type 1-infected individuals undergoing HAART.
    Cosma A; Nagaraj R; Staib C; Diemer C; Wopfner F; Schätzl H; Busch DH; Sutter G; Goebel FD; Erfle V
    AIDS Res Hum Retroviruses; 2007 Jun; 23(6):782-93. PubMed ID: 17604541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.